Reata rises on renal interest from Amgen
Reata gained $24.75 (13%) to $218.79 Friday, adding about $750 million in market cap, after Amgen expressed
Having trouble accessing articles? Reset your cache.
Gathering data...
Reata gained $24.75 (13%) to $218.79 Friday, adding about $750 million in market cap, after Amgen expressed